中文产业新闻评分70Chinese source
BMS核药RYZ101三期ACTION-1研究达PFS主要终点，市值盘前涨超400亿元
这款核药临床三期成功，市值涨超400亿
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
这款核药临床三期成功，市值涨超400亿
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.